Israeli Cannabis Producer Touts Record Q3 Revenue, Gross Profit Increase
InterCure Reports Record Preliminary Q2 2022 Revenue – More Than Double YoY
InterCure Reports Record FY 2021 Revenue Of $89M, Q4 Adjusted EBITDA Spikes 140% YoY
InterCure To Acquire Israel-Based Medical Cannabis Producer Better For $35M